A call to action for the use of composite hematologic measurements in hereditary hemorrhagic telangiectasia and other chronic bleeding disorders

Expert Review of Hematology · Published 2026-06-08 · DOI 10.1080/17474086.2026.2686409

Free full text

Authors (16)

Hanny Al-Samkari, Raj S. Kasthuri, Jenny Y. Zhou, Layla N. Van Doren, Keith R. McCrae, Allyson M. Pishko, Adrienne Hammill, Magdalena Lewandowska, Quentin Van Thillo, Ibrahim Ibrahim, Kenneth S. Cohen, Bryan Sisk, Diana M. Byrnes, Senthil Sukumar, Patrick Foy, Bethany T. Samuelson Bannow

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Al-Samkari, H., Kasthuri, R., Zhou, J., et al. (2026). A call to action for the use of composite hematologic measurements in hereditary hemorrhagic telangiectasia and other chronic bleeding disorders. Expert Review of Hematology. https://doi.org/10.1080/17474086.2026.2686409

Related articles

• Systemic Bevacizumab for Severe Bleeding From Acquired Gastrointestinal Vascular Malformations · American Journal of Hematology · 2026 · Cites or is cited by this article
• Polycythemia vera and metabolic syndrome: is the relationship between the two diseases more than we think? · Expert Review of Hematology · 2026 · Same journal
• Challenges faced by women and girls with hemophilia/Carriers: an expert call for closing the diagnosis gap · Expert Review of Hematology · 2026 · Same journal
• Social challenges and support needs of patients with hemophilia in Pakistan: a qualitative exploratory study · Expert Review of Hematology · 2026 · Same journal
• Autoimmune cytopenias in chronic lymphocytic leukemia in the era of novel drugs · Expert Review of Hematology · 2026 · Same journal
• A Review of Disparities in Autologous Stem Cell Transplantation in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma · Expert Review of Hematology · 2026 · Same journal
• Efficacy of pacritinib versus momelotinib in patients with thrombocytopenic myelofibrosis: a matching-adjusted indirect treatment comparison · Expert Review of Hematology · 2026 · Same journal
• An interview with Dr Joshua Richter on his experience as an investigator for linvoseltamab-gcpt - by Reegan Burnell-Clarke (Commissioning Editor) · Expert Review of Hematology · 2026 · Same journal
• Reconsidering time from diagnosis to treatment in acute myeloid leukemia: from therapeutic urgency to biologically informed timing · Expert Review of Hematology · 2026 · Same journal
• Apparent plateaus during iron chelation in transfusion-dependent β-thalassemia: interpretation and clinical implications · Expert Review of Hematology · 2026 · Same journal